2c:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/1bqb83_yclja0.js","/_next/static/immutable/chunks/1on664om2hmh1.js","/_next/static/immutable/chunks/30t4sjq-27eg7.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/32zk736rs0hqw.js","/_next/static/immutable/chunks/0lbgs964whs_0.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js","/_next/static/immutable/chunks/0hcnvyarhzl7i.js"],"default"] 2d:T5c2b,

CATEGORY	DETAILS
RISK FACTORS	Young males aged 15 to 40, HLA-B27 positive (present in ~90% of patients), positive family history of spondyloarthropathy
ETIOLOGY	Chronic immune-mediated inflammatory enthesopathy with strong genetic predisposition linked to the HLA-B27 allele; exact trigger remains unclear but involves aberrant immune activation at entheses
PATIENT PRESENTATION	Insidious onset of chronic low back pain and morning stiffness lasting more than 30 minutes that improves with physical activity and worsens with prolonged rest or inactivity
CLASSIC PHYSICAL EXAM	Reduced lumbar flexion on Schober test (less than 5 cm excursion), decreased chest expansion (less than 5 cm), loss of normal lumbar lordosis, exaggerated thoracic kyphosis, sacroiliac joint tenderness, and a stooped forward posture in advanced disease
KEY DIAGNOSTIC RESULTS	X-ray showing bilateral sacroiliitis (early) progressing to vertebral squaring, syndesmophytes, and "bamboo spine" (late); MRI showing bone marrow edema at sacroiliac joints in early or pre-radiographic disease; elevated ESR and CRP; positive HLA-B27
MANAGEMENT	First-line: NSAIDs (indomethacin or naproxen) with regular physical therapy; Second-line: TNF-alpha inhibitors (adalimumab, etanercept) for NSAID-refractory disease; IL-17A inhibitor (secukinumab) as alternative biologic; sulfasalazine only for peripheral joint involvement
KEYWORDS	"Morning stiffness improving with exercise," "young male with chronic back pain," "bamboo spine," "bilateral sacroiliitis," "HLA-B27," "enthesitis," "inflammatory back pain"

1. Pathophysiology

Ankylosing spondylitis is the prototypical axial spondyloarthropathy, driven by a chronic inflammatory process that targets the entheses, the sites where tendons, ligaments, and joint capsules insert into bone. The disease has a profound genetic underpinning: the HLA-B27 allele is present in approximately 90% of affected patients, though it is important to remember that most HLA-B27 positive individuals never develop the disease. The current understanding is that HLA-B27 may misfold within the endoplasmic reticulum, triggering an unfolded protein response that activates IL-23/IL-17 inflammatory pathways, or it may present arthritogenic peptides that provoke a cytotoxic T-cell response.

The primary battleground is the sacroiliac joint, which is why sacroiliitis is the earliest and most characteristic radiographic finding. From the sacroiliac joints, inflammation ascends along the axial skeleton. At the entheses, chronic inflammation leads to erosion of the underlying bone, followed by a reparative process involving reactive new bone formation. This is the critical concept: destruction followed by inappropriate ossification. Over time, bridging bony outgrowths called syndesmophytes form between adjacent vertebral bodies. These syndesmophytes are thin, vertical, and marginal (arising from the vertebral rim), distinguishing them from the bulky, horizontal osteophytes of degenerative disease. When syndesmophytes fuse across multiple segments, the result is the classic "bamboo spine" appearance on X-ray, a rigid, immobile spinal column.

This pathophysiology directly explains the clinical presentation. Early inflammation at the sacroiliac joints and lumbar spine causes pain and stiffness that is worst after periods of inactivity (e.g., upon waking) because inflammatory cytokines and edema accumulate when the joints are not moving. Physical activity improves symptoms because movement disperses the inflammatory exudate and increases blood flow. This is the hallmark of inflammatory back pain and the single most important clinical feature that separates this condition from mechanical back pain, which follows the opposite pattern.

The extra-articular manifestations also connect to the underlying immune dysregulation. Anterior uveitis (acute, unilateral, painful red eye) is the most common extra-articular feature, occurring in up to 40% of patients. Aortitis and aortic regurgitation result from inflammation of the aortic root. Apical pulmonary fibrosis (upper lobe fibrosis) is a rare but classic association. These three "A" complications (Anterior uveitis, Aortitis, Apical fibrosis) are high-yield associations tested in vignettes.

2. Classification and Clinical Manifestation

CLASSIFICATION	DESCRIPTION	KEY FEATURES
Axial spondyloarthropathy (non-radiographic)	Early-stage disease without definitive X-ray changes	Inflammatory back pain, sacroiliac bone marrow edema on MRI only, positive HLA-B27 supportive
Axial spondyloarthropathy (radiographic) = Ankylosing spondylitis	Established disease meeting modified New York criteria with definitive sacroiliitis on plain X-ray	Bilateral grade 2 or unilateral grade 3-4 sacroiliitis plus at least one clinical criterion (inflammatory back pain, limited lumbar motion, decreased chest expansion)
Peripheral involvement	Involvement of joints outside the axial skeleton	Asymmetric oligoarthritis preferring large joints (hips, knees, shoulders); dactylitis (sausage digits); enthesitis at Achilles tendon or plantar fascia

EXTRA-ARTICULAR MANIFESTATION	FREQUENCY	CLINICAL SIGNIFICANCE
Anterior uveitis (iritis)	Up to 40%	Most common extra-articular feature; acute, unilateral, painful red eye with photophobia; can precede spinal symptoms
Aortitis and aortic regurgitation	3 to 10%	Inflammation of ascending aorta root; presents as diastolic murmur; may cause conduction abnormalities
Apical pulmonary fibrosis	Rare (less than 2%)	Upper lobe restrictive pattern; may mimic tuberculosis on chest X-ray
IgA nephropathy	Uncommon	Secondary to chronic inflammatory state; microscopic hematuria
Cauda equina syndrome	Rare, late complication	Occurs due to arachnoiditis or dural ectasia in long-standing disease; bladder dysfunction, saddle anesthesia
Osteoporosis and spinal fracture	Significant in advanced disease	Fused, osteoporotic spine is brittle; minor trauma can cause unstable fractures, especially at cervicothoracic junction

3. Diagnostic Workup

TEST	ROLE	EXPECTED FINDINGS
X-ray of sacroiliac joints and lumbar spine	Best initial test	Early: bilateral sacroiliitis (blurring of joint margins, erosions, sclerosis). Late: vertebral squaring ("Romanus lesion"), syndesmophytes, bamboo spine, "dagger sign" (ossification of supraspinous and interspinous ligaments)
MRI of sacroiliac joints	Most accurate test for early disease	Bone marrow edema (hyperintense signal on STIR/T2 sequences) at sacroiliac joints, indicating active inflammation before structural damage is radiographically visible
HLA-B27	Supportive, not diagnostic	Positive in approximately 90% of patients; useful when clinical suspicion is high but imaging is equivocal; a negative result does not exclude the diagnosis
ESR and CRP	Markers of disease activity	Elevated in active disease; useful for monitoring treatment response but normal values do not rule out the diagnosis
Schober test	Clinical bedside assessment	Less than 5 cm of lumbar excursion during forward flexion indicates restricted spinal mobility
Chest expansion measurement	Clinical bedside assessment	Less than 5 cm at the fourth intercostal space suggests costovertebral joint involvement
Rheumatoid factor and anti-CCP	Exclusionary	Negative; ankylosing spondylitis is a seronegative spondyloarthropathy; if positive, consider rheumatoid arthritis

The diagnostic approach begins with clinical recognition of inflammatory back pain. The distinguishing features are: onset before age 40, insidious onset, duration greater than 3 months, morning stiffness lasting more than 30 minutes, and improvement with exercise but not with rest. When a vignette describes a young patient with these features, the next step is plain X-ray of the sacroiliac joints and lumbar spine.

If X-ray shows bilateral sacroiliitis, the diagnosis is essentially confirmed in the correct clinical context using the modified New York criteria. However, radiographic changes may take years to develop. When the clinical picture is strongly suggestive but X-rays are normal or equivocal, the next best step is MRI of the sacroiliac joints. MRI can detect bone marrow edema (osteitis) at the sacroiliac joints, which represents active inflammation before erosive or sclerotic changes become visible on plain film. This is the concept of non-radiographic axial spondyloarthropathy, and MRI is the most sensitive imaging modality for detecting it.

HLA-B27 is supportive but never diagnostic on its own. Approximately 6 to 8% of the general population carries HLA-B27 without disease. It should be ordered when clinical suspicion exists and imaging is inconclusive, but the diagnosis should never rest on HLA-B27 positivity alone. Exam questions that present HLA-B27 as the definitive answer to "what confirms the diagnosis?" are designed as traps.

Rheumatoid factor and anti-CCP antibodies are expected to be negative. Ankylosing spondylitis belongs to the seronegative spondyloarthropathy family. If these markers are positive, you should reconsider the diagnosis and think about rheumatoid arthritis or overlap syndromes.

4. Management and Treatment

INTERVENTION	DETAILS	NOTES
NSAIDs (first-line)	Indomethacin 25 to 50 mg two to three times daily, or naproxen 500 mg twice daily; continuous rather than on-demand dosing is preferred for active axial disease	Minimum trial of at least 2 different NSAIDs for a total of 4 weeks before declaring failure; the only drug class with evidence for slowing radiographic progression in some studies
Physical therapy and exercise	Daily stretching, range-of-motion exercises, posture training, and cardiovascular fitness	Considered a cornerstone of long-term management alongside pharmacotherapy; helps maintain spinal mobility and prevents deformity
TNF-alpha inhibitors (second-line)	Adalimumab 40 mg subcutaneously every 2 weeks, or etanercept 50 mg subcutaneously weekly, or infliximab 5 mg/kg intravenously at weeks 0, 2, 6, then every 6 to 8 weeks	Indicated when patients fail at least 2 NSAIDs; highly effective for both symptoms and inflammation; screen for latent tuberculosis and hepatitis B before initiation
IL-17A inhibitors (alternative biologic)	Secukinumab 150 mg subcutaneously at weeks 0, 1, 2, 3, 4, then every 4 weeks	Used when TNF-alpha inhibitors are contraindicated or have failed; avoid in patients with active inflammatory bowel disease as IL-17 blockade may worsen it
Sulfasalazine	500 mg daily, titrated up to 2 to 3 g daily in divided doses	Only effective for peripheral joint disease; no evidence of benefit for axial (spinal) symptoms
Local corticosteroid injection	Intra-articular or peritendinous injection	May be used for isolated peripheral enthesitis or arthritis; systemic corticosteroids have no role in axial disease management
Surgery (total hip arthroplasty)	For severe, refractory hip joint destruction	Hip involvement carries a worse functional prognosis; surgical replacement significantly improves quality of life

Acute management centers on NSAIDs, which remain the first-line pharmacotherapy. Unlike their use in other rheumatic conditions where they serve only as symptom relief, in ankylosing spondylitis NSAIDs may have a disease-modifying effect on radiographic progression when used continuously. Indomethacin has the longest track record, but naproxen or other NSAIDs are acceptable alternatives. The key exam point is that patients should trial at least two different NSAIDs, each for a minimum of 2 weeks (total 4 weeks), before treatment is considered to have failed.

Long-term management for patients who do not respond to NSAIDs involves escalation to biologic therapy. TNF-alpha inhibitors are the preferred second-line agents. Before starting any TNF-alpha inhibitor, you must screen for latent tuberculosis (tuberculin skin test or interferon-gamma release assay) and hepatitis B (HBsAg, anti-HBc, anti-HBs), because TNF blockade can reactivate these infections. This screening step is a common exam question.

An important principle tested on exams is knowing what does not work for axial disease. Methotrexate, sulfasalazine, and systemic corticosteroids are ineffective for spinal (axial) symptoms. Sulfasalazine has a limited role restricted to peripheral joint involvement only. Systemic glucocorticoids are not recommended. These are common wrong answer choices designed to test whether students inappropriately generalize rheumatoid arthritis treatment to ankylosing spondylitis.

Physical therapy is not optional adjunctive care; it is a core component of management. Regular exercise and postural training help maintain spinal range of motion, prevent fusion in a kyphotic position, and reduce long-term disability.

5. Differential Diagnosis and Distractors

DIFFERENTIAL	WHY IT IS SIMILAR	KEY DISCRIMINATOR
Mechanical (degenerative) low back pain	Also presents with chronic low back pain in adults	Pain pattern is reversed: mechanical pain worsens with activity and improves with rest; no morning stiffness exceeding 30 minutes; onset typically after age 40; X-ray shows osteophytes and disc space narrowing, not sacroiliitis
Reactive arthritis (Reiter syndrome)	Spondyloarthropathy, HLA-B27 associated, can cause sacroiliitis and inflammatory back pain	Post-infectious onset (urethritis, diarrhea); classic triad of urethritis, conjunctivitis (not uveitis), and asymmetric oligoarthritis; sacroiliitis if present is often unilateral
Psoriatic arthritis (axial form)	Can involve sacroiliac joints and spine; HLA-B27 associated	Look for skin or nail findings (psoriatic plaques, nail pitting, onycholysis); syndesmophytes tend to be non-marginal, asymmetric, and bulky ("jug-handle"); DIP joint involvement is characteristic
Diffuse idiopathic skeletal hyperostosis (DISH)	Flowing ossification along the spine that can mimic bamboo spine on imaging	Occurs in older patients (over 50), often with metabolic syndrome or type 2 diabetes; ossification involves the anterolateral aspect of at least 4 contiguous vertebrae; sacroiliac joints are preserved and normal
Enteropathic arthritis	Sacroiliitis and inflammatory back pain occurring with inflammatory bowel disease (Crohn or ulcerative colitis)	Gastrointestinal symptoms dominate (bloody diarrhea, abdominal pain, weight loss); articular symptoms often flare with bowel disease activity; distinguish from isolated ankylosing spondylitis by prominent GI history
Lumbar spinal stenosis	Chronic back pain with stiffness in older adults	Neurogenic claudication (pain radiating to legs worsened by walking and relieved by bending forward); MRI shows central canal narrowing; no sacroiliitis or inflammatory markers

6. Traps and High-Yield Pearls

The most common way students lose points on ankylosing spondylitis questions is by failing to recognize the pattern of inflammatory back pain. The vignette will describe a young male with chronic low back pain, and the distinguishing detail will be buried in one line: "stiffness is worst in the morning and improves as the day goes on" or "symptoms are relieved by exercise." Students who do not immediately flag this as inflammatory rather than mechanical will be steered toward degenerative disease or disc herniation and select the wrong workup.

The second major trap involves HLA-B27. Test-writers frequently offer HLA-B27 as the "confirmatory test" or "best next step." It is neither. HLA-B27 is supportive evidence, but the diagnosis is confirmed by imaging (X-ray showing sacroiliitis, or MRI showing bone marrow edema when X-rays are normal). Choosing HLA-B27 as the most accurate test is a reliably wrong answer.

A third pitfall is applying rheumatoid arthritis treatment logic to ankylosing spondylitis. Students who select methotrexate or systemic corticosteroids for axial disease are making a category error. These agents have no proven benefit for spinal inflammation in ankylosing spondylitis. The correct escalation pathway is NSAIDs followed by TNF-alpha inhibitors, not NSAIDs followed by methotrexate.

Finally, remember the extra-articular associations. A vignette may present a patient with known ankylosing spondylitis who develops an acute red, painful eye. The answer is anterior uveitis, and the next step is slit-lamp examination and ophthalmology referral, not a new rheumatologic workup. Similarly, if a patient with long-standing bamboo spine presents after minor trauma with sudden neurological deficits, think unstable spinal fracture through a fused, osteoporotic spine. The fused spine is paradoxically more fragile, not more protected.

The core competency being tested across all ankylosing spondylitis questions is your ability to distinguish inflammatory from mechanical back pain, sequence imaging correctly (X-ray first, MRI for early disease), and apply the correct treatment algorithm without borrowing from rheumatoid arthritis management.

1d:["$","$L2c",null,{"article":{"id":"5e81cff4-0025-4d4b-832e-8aee88b68d5a","title":"Ankylosing Spondylitis","content":"$2d","category":"Muskuloskeletal","created_at":"2026-09-06T05:01:50.633801+00:00","status":"published","subcategory":null},"questionCount":0,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]